ELECTRONIC ARTICLE |
Early Extubation and Nasal Continuous Positive Airway Pressure After Surfactant Treatment for Respiratory Distress Syndrome Among Preterm Infants <30 Weeks Gestation
From the Department of Surgical and Medical Critical Care, Division of Neonatology, Careggi University Hospital of Florence, Florence, Italy
Objective. To test the hypothesis that preterm infants with infant respiratory distress syndrome who are treated with nasal continuous positive airway pressure (NCPAP) and surfactant administration followed by immediate extubation and NCPAP application (SURF-NCPAP group) demonstrate less need for mechanical ventilation (MV), compared with infants who receive MV after surfactant administration (SURF-MV group).
Methods. A prospective randomized study was conducted, in which infants <30 weeks gestation were randomized to the SURF-NCPAP group or the SURF-MV group.
Results. At 7 days of life, no patient in the SURF-NCPAP group but 6 patients (43%) in the SURF-MV group still were undergoing MV. The duration of oxygen therapy, NCPAP, and MV, the need for a second dose of surfactant, and the length of stay in the intensive care unit were significantly greater in the SURF-MV group.
Conclusions. The immediate reinstitution of NCPAP after surfactant administration for infants with infant respiratory distress syndrome is safe and beneficial, as indicated by the lesser need for MV and the briefer requirement for respiratory supports, compared with the institution of MV after surfactant treatment. Moreover, this strategy contributed to reducing the need for surfactant treatment and reducing the time and costs involved in keeping the infants in the neonatal intensive care unit.
Key Words: continuous positive airway pressure mechanical ventilation surfactant respiratory distress syndrome infant
Abbreviations: a/APO2, arterial/alveolar oxygen tension ratio iRDS, infant respiratory distress syndrome MV, mechanical ventilation NCPAP, nasal continuous positive airway pressure SURF-MV, mechanical ventilation after surfactant treatment SURF-NCPAP, nasal continuous positive airway pressure after surfactant treatment FIO2, fraction of inspired oxygen IVH, intraventricular hemorrhage BPD, bronchopulmonary dysplasia ROP, retinopathy of prematurity PDA, patent ductus arteriosus
Received for publication Nov 10, 2003; Accepted Jan 28, 2004.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. Kugelman International Perspectives: Nasal Ventilation in Preterm Infants: An Israeli Perspective NeoReviews, April 1, 2009; 10(4): e157 - e165. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Eichenwald and A. R. Stark Management and Outcomes of Very Low Birth Weight N. Engl. J. Med., April 17, 2008; 358(16): 1700 - 1711. [Full Text] [PDF] |
||||
![]() |
I. Frerichs, P. A. Dargaville, H. van Genderingen, D. R. Morel, and P. C. Rimensberger Lung Volume Recruitment after Surfactant Administration Modifies Spatial Distribution of Ventilation Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 772 - 779. [Abstract] [Full Text] [PDF] |
||||







